Weekly update Companies AI-cruiter Recruiting

Reneo Pharmaceuticals

Reneo Pharmaceuticals

Founded: 2018

Location: Irvine, CA

Employee range: 11 - 50

Clinical stage: Clin2/Clin3

Therapy area: Mitochondrial myopathies

Drug types: GEN, MUS, RAR

Lead product: REN001

Product link: https://reneopharma.com/programs/

Funding: $55M stock May 2023; $93.8M IPO Apr 2021; $95M B Dec 2020; $50M May 2019; $50M total Dec 2018

Investors: Lundbeckfonden, NEA, Pappas Capital, RiverVest

reneopharma.com

Short description:

Genetically-Defined Orphan Therapies

Drug notes:

Also additional Clin2 mitochondrial myopathies, Clin2 fatty acid oxidation disorders (ODD)

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

Main

© 2024 Work In Biotech LLC

Terms of Service

Contact: recruit@workinbiotech.com